At UMass Memorial Cancer Center of Excellence in Worcester, MA, we work in partnership with the University of Massachusetts Medical School to research new treatments for cancer. UMass Memorial is at the forefront of some of the nation’s most promising research and treatment programs. Through our Cancer Center Clinical Research Office (CRO), we perform breakthrough research and clinical trials
to improve treatment and your quality of life.
Liver Cancer Trials Underway
|
ImClone REACH
A multicenter, randomized, double-blind, phase 3 study of Ramucirumab (IMC-1121B) drug product and best supportive care (BSC) versus placebo and BSC as second-line treatment in patients with hepatocellular carcinoma following first-line therapy with sorafenib
INVESTIGATOR: Venu Bathini, MD
SPONSOR: ImClone LLC (a wholly-owned subsidiary of Eli Lilly and Company)
ImClone REACH at clinicaltrials.gov
|
Learn more about research and other clinical trials underway at the UMass Memorial Cancer Center of Excellence.
|
Liver Cancer Studies Recruiting:
To learn more about clinical trials and cancer research,
call 508-856-3216 or email cancer.research@umassmed.edu
|